Label Value
DOI 10.1038/srep31542
TITLE Reduction of obesity-associated white adipose tissue inflammation by rosiglitazone is associated with reduced non-alcoholic fatty liver disease in LDLr-deficient mice
TYPE article
PUBLICATION DATE
Service Status Date Last Checked
Scopus Yes 2018-02-12T11:34:21.367794
Web of Science Yes 2018-04-10T03:02:38.210319
Compendex No 2020-10-15T19:16:00.601704